Risankizumab trials for Crohn's disease

All Risankizumab trials · All Crohn's disease trials

Phase breakdown

Recruiting trials studying Risankizumab for Crohn's disease

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
  NCT07499232 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 160 locations
• A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
  NCT05995353 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 85 locations
• Risankizumab in Children With Crohn's Disease (RisaKids)
  NCT06298188 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 18 Years · Sex: All (male and female) · 1 location
• Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
  NCT07697456 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 68 locations
• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
  NCT06548542 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 255 locations
• Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
  NCT04846959 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 4 locations

Common questions

How many trials study Risankizumab for Crohn's disease?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.